Obesity has often been framed as a “lifestyle disease,” blaming individual people for not having enough willpower. But diets are shaped by what food is available, what it costs, how it’s marketed, where shops are located, and what’s most convenient. In many high-income countries, it is remarkably easy to consume large amounts of cheap, energy-dense food. Society tells people to make healthier choices while surrounding them with an environment that often encourages the opposite.
The UK government-commissioned national food strategy, finalized in 2021, made this point clearly: improving diets can’t simply be about asking individuals to choose better. The wider food environment needs to change to make the better choice the easy one.
Our findings shouldn’t be taken to mean that people living with obesity have a responsibility to lose weight to reduce the environmental impacts of food production. Rather, our research examines the wider consequences that changes in food demand could have across the food system.
Changing the food system alongside medicine
A healthier diet is not necessarily just a diet with fewer calories. It could mean more fruit, vegetables, and other nutritious foods, alongside less excessive consumption of foods linked to poor health. These changes affect not only human health but also agriculture, land use, and the environment.
Rather than asking whether GLP-1 medications or healthier diets are the answer, let’s ask how they can work together. Imagine a food system where healthier foods are affordable and accessible, unhealthy options aren’t relentlessly promoted, agricultural policy supports nutritious and sustainable production, and people who need medical treatment can access it. That combination could be far more powerful than any single intervention.
GLP-1 medicines can play an important role in tackling obesity, but they shouldn’t become a technological fix that allows the wider food system to escape scrutiny. They can help people eat less in an unhealthy food environment, but the long-term goal should be to make it easier and more affordable to have a healthier, more sustainable diet.
The remarkable thing about GLP-1 medications may not be that they change how much food people eat. It may be that they show us, with new clarity, just how closely human health, food production, and environmental health are connected, and how much could be gained if we tackled all three together.
Roslyn Henry is Lecturer, School of Biological Sciences, University of Aberdeen and Peter Alexander is Professor of Global Food Systems, University of Edinburgh.
This article is republished from The Conversation under a Creative Commons license. Read the original article.
Source: Ars Technica · The Conversation
At a glance
- Topic
- Health
- Country
- 🇺🇸 US
- Publisher language
- EN
- Added to Allnira